Renal Therapeutic Market, Global Outlook and Forecast 2022-2028

August 2022 | 60 pages | ID: R753146037FAEN
Market Monitor Global

Abstracts

Chronic kidney disease (CKD) is a slow and progressive loss of kidney function over several years. Eventually, a person may develop kidney failure.

This report contains market size and forecasts of Renal Therapeutic in Global, including the following market information:

Global Renal Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Renal Therapeutic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Angiotensin-II Receptor Blockers Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Renal Therapeutic include Merck & Co., Inc., Bristol-Myers Squibb Company, Novartis AG, Pfizer Inc., Vifor Pharma Inc., Johnson & Johnson Services, Inc., Amgen Inc., Bayer AG and AstraZeneca and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Renal Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Renal Therapeutic Market, by Drug Type, 2017-2022, 2023-2028 ($ millions)

Global Renal Therapeutic Market Segment Percentages, by Drug Type, 2021 (%)

• Angiotensin-II Receptor Blockers
• ACE Inhibitors
• Calcium Channel Blockers
• Beta-blockers
• Others

Global Renal Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Renal Therapeutic Market Segment Percentages, by Application, 2021 (%)

• Chronic Kidney Disease
• Diabetes
• Kidney Stone Disease
• Renal Failure
• Others

Global Renal Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Renal Therapeutic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Renal Therapeutic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Renal Therapeutic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck & Co., Inc.
• Bristol-Myers Squibb Company
• Novartis AG
• Pfizer Inc.
• Vifor Pharma Inc.
• Johnson & Johnson Services, Inc.
• Amgen Inc.
• Bayer AG
• AstraZeneca
• Vifor Pharma Group

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Renal Therapeutic Market Definition
1.2 Market Segments
  1.2.1 Market by Drug Type
  1.2.2 Market by Application
1.3 Global Renal Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RENAL THERAPEUTIC OVERALL MARKET SIZE

2.1 Global Renal Therapeutic Market Size: 2021 VS 2028
2.2 Global Renal Therapeutic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Renal Therapeutic Players in Global Market
3.2 Top Global Renal Therapeutic Companies Ranked by Revenue
3.3 Global Renal Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Renal Therapeutic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Renal Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Renal Therapeutic Players in Global Market
  3.6.1 List of Global Tier 1 Renal Therapeutic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Renal Therapeutic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Drug Type - Global Renal Therapeutic Market Size Markets, 2021 & 2028
  4.1.2 Angiotensin-II Receptor Blockers
  4.1.3 ACE Inhibitors
  4.1.4 Calcium Channel Blockers
  4.1.5 Beta-blockers
  4.1.6 Others
4.2 By Drug Type - Global Renal Therapeutic Revenue & Forecasts
  4.2.1 By Drug Type - Global Renal Therapeutic Revenue, 2017-2022
  4.2.2 By Drug Type - Global Renal Therapeutic Revenue, 2023-2028
  4.2.3 By Drug Type - Global Renal Therapeutic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Renal Therapeutic Market Size, 2021 & 2028
  5.1.2 Chronic Kidney Disease
  5.1.3 Diabetes
  5.1.4 Kidney Stone Disease
  5.1.5 Renal Failure
  5.1.6 Others
5.2 By Application - Global Renal Therapeutic Revenue & Forecasts
  5.2.1 By Application - Global Renal Therapeutic Revenue, 2017-2022
  5.2.2 By Application - Global Renal Therapeutic Revenue, 2023-2028
  5.2.3 By Application - Global Renal Therapeutic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Renal Therapeutic Market Size, 2021 & 2028
6.2 By Region - Global Renal Therapeutic Revenue & Forecasts
  6.2.1 By Region - Global Renal Therapeutic Revenue, 2017-2022
  6.2.2 By Region - Global Renal Therapeutic Revenue, 2023-2028
  6.2.3 By Region - Global Renal Therapeutic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Renal Therapeutic Revenue, 2017-2028
  6.3.2 US Renal Therapeutic Market Size, 2017-2028
  6.3.3 Canada Renal Therapeutic Market Size, 2017-2028
  6.3.4 Mexico Renal Therapeutic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Renal Therapeutic Revenue, 2017-2028
  6.4.2 Germany Renal Therapeutic Market Size, 2017-2028
  6.4.3 France Renal Therapeutic Market Size, 2017-2028
  6.4.4 U.K. Renal Therapeutic Market Size, 2017-2028
  6.4.5 Italy Renal Therapeutic Market Size, 2017-2028
  6.4.6 Russia Renal Therapeutic Market Size, 2017-2028
  6.4.7 Nordic Countries Renal Therapeutic Market Size, 2017-2028
  6.4.8 Benelux Renal Therapeutic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Renal Therapeutic Revenue, 2017-2028
  6.5.2 China Renal Therapeutic Market Size, 2017-2028
  6.5.3 Japan Renal Therapeutic Market Size, 2017-2028
  6.5.4 South Korea Renal Therapeutic Market Size, 2017-2028
  6.5.5 Southeast Asia Renal Therapeutic Market Size, 2017-2028
  6.5.6 India Renal Therapeutic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Renal Therapeutic Revenue, 2017-2028
  6.6.2 Brazil Renal Therapeutic Market Size, 2017-2028
  6.6.3 Argentina Renal Therapeutic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Renal Therapeutic Revenue, 2017-2028
  6.7.2 Turkey Renal Therapeutic Market Size, 2017-2028
  6.7.3 Israel Renal Therapeutic Market Size, 2017-2028
  6.7.4 Saudi Arabia Renal Therapeutic Market Size, 2017-2028
  6.7.5 UAE Renal Therapeutic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck & Co., Inc.
  7.1.1 Merck & Co., Inc. Corporate Summary
  7.1.2 Merck & Co., Inc. Business Overview
  7.1.3 Merck & Co., Inc. Renal Therapeutic Major Product Offerings
  7.1.4 Merck & Co., Inc. Renal Therapeutic Revenue in Global Market (2017-2022)
  7.1.5 Merck & Co., Inc. Key News
7.2 Bristol-Myers Squibb Company
  7.2.1 Bristol-Myers Squibb Company Corporate Summary
  7.2.2 Bristol-Myers Squibb Company Business Overview
  7.2.3 Bristol-Myers Squibb Company Renal Therapeutic Major Product Offerings
  7.2.4 Bristol-Myers Squibb Company Renal Therapeutic Revenue in Global Market (2017-2022)
  7.2.5 Bristol-Myers Squibb Company Key News
7.3 Novartis AG
  7.3.1 Novartis AG Corporate Summary
  7.3.2 Novartis AG Business Overview
  7.3.3 Novartis AG Renal Therapeutic Major Product Offerings
  7.3.4 Novartis AG Renal Therapeutic Revenue in Global Market (2017-2022)
  7.3.5 Novartis AG Key News
7.4 Pfizer Inc.
  7.4.1 Pfizer Inc. Corporate Summary
  7.4.2 Pfizer Inc. Business Overview
  7.4.3 Pfizer Inc. Renal Therapeutic Major Product Offerings
  7.4.4 Pfizer Inc. Renal Therapeutic Revenue in Global Market (2017-2022)
  7.4.5 Pfizer Inc. Key News
7.5 Vifor Pharma Inc.
  7.5.1 Vifor Pharma Inc. Corporate Summary
  7.5.2 Vifor Pharma Inc. Business Overview
  7.5.3 Vifor Pharma Inc. Renal Therapeutic Major Product Offerings
  7.5.4 Vifor Pharma Inc. Renal Therapeutic Revenue in Global Market (2017-2022)
  7.5.5 Vifor Pharma Inc. Key News
7.6 Johnson & Johnson Services, Inc.
  7.6.1 Johnson & Johnson Services, Inc. Corporate Summary
  7.6.2 Johnson & Johnson Services, Inc. Business Overview
  7.6.3 Johnson & Johnson Services, Inc. Renal Therapeutic Major Product Offerings
  7.6.4 Johnson & Johnson Services, Inc. Renal Therapeutic Revenue in Global Market (2017-2022)
  7.6.5 Johnson & Johnson Services, Inc. Key News
7.7 Amgen Inc.
  7.7.1 Amgen Inc. Corporate Summary
  7.7.2 Amgen Inc. Business Overview
  7.7.3 Amgen Inc. Renal Therapeutic Major Product Offerings
  7.7.4 Amgen Inc. Renal Therapeutic Revenue in Global Market (2017-2022)
  7.7.5 Amgen Inc. Key News
7.8 Bayer AG
  7.8.1 Bayer AG Corporate Summary
  7.8.2 Bayer AG Business Overview
  7.8.3 Bayer AG Renal Therapeutic Major Product Offerings
  7.8.4 Bayer AG Renal Therapeutic Revenue in Global Market (2017-2022)
  7.8.5 Bayer AG Key News
7.9 AstraZeneca
  7.9.1 AstraZeneca Corporate Summary
  7.9.2 AstraZeneca Business Overview
  7.9.3 AstraZeneca Renal Therapeutic Major Product Offerings
  7.9.4 AstraZeneca Renal Therapeutic Revenue in Global Market (2017-2022)
  7.9.5 AstraZeneca Key News
7.10 Vifor Pharma Group
  7.10.1 Vifor Pharma Group Corporate Summary
  7.10.2 Vifor Pharma Group Business Overview
  7.10.3 Vifor Pharma Group Renal Therapeutic Major Product Offerings
  7.10.4 Vifor Pharma Group Renal Therapeutic Revenue in Global Market (2017-2022)
  7.10.5 Vifor Pharma Group Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Renal Therapeutic Market Opportunities & Trends in Global Market
Table 2. Renal Therapeutic Market Drivers in Global Market
Table 3. Renal Therapeutic Market Restraints in Global Market
Table 4. Key Players of Renal Therapeutic in Global Market
Table 5. Top Renal Therapeutic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Renal Therapeutic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Renal Therapeutic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Renal Therapeutic Product Type
Table 9. List of Global Tier 1 Renal Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Renal Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Drug Type – Global Renal Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Drug Type - Renal Therapeutic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Drug Type - Renal Therapeutic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Renal Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Renal Therapeutic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Renal Therapeutic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Renal Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Renal Therapeutic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Renal Therapeutic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Renal Therapeutic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Renal Therapeutic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Renal Therapeutic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Renal Therapeutic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Renal Therapeutic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Renal Therapeutic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Renal Therapeutic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Renal Therapeutic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Renal Therapeutic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Renal Therapeutic Revenue, (US$, Mn), 2023-2028
Table 30. Merck & Co., Inc. Corporate Summary
Table 31. Merck & Co., Inc. Renal Therapeutic Product Offerings
Table 32. Merck & Co., Inc. Renal Therapeutic Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Company Corporate Summary
Table 34. Bristol-Myers Squibb Company Renal Therapeutic Product Offerings
Table 35. Bristol-Myers Squibb Company Renal Therapeutic Revenue (US$, Mn), (2017-2022)
Table 36. Novartis AG Corporate Summary
Table 37. Novartis AG Renal Therapeutic Product Offerings
Table 38. Novartis AG Renal Therapeutic Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Inc. Corporate Summary
Table 40. Pfizer Inc. Renal Therapeutic Product Offerings
Table 41. Pfizer Inc. Renal Therapeutic Revenue (US$, Mn), (2017-2022)
Table 42. Vifor Pharma Inc. Corporate Summary
Table 43. Vifor Pharma Inc. Renal Therapeutic Product Offerings
Table 44. Vifor Pharma Inc. Renal Therapeutic Revenue (US$, Mn), (2017-2022)
Table 45. Johnson & Johnson Services, Inc. Corporate Summary
Table 46. Johnson & Johnson Services, Inc. Renal Therapeutic Product Offerings
Table 47. Johnson & Johnson Services, Inc. Renal Therapeutic Revenue (US$, Mn), (2017-2022)
Table 48. Amgen Inc. Corporate Summary
Table 49. Amgen Inc. Renal Therapeutic Product Offerings
Table 50. Amgen Inc. Renal Therapeutic Revenue (US$, Mn), (2017-2022)
Table 51. Bayer AG Corporate Summary
Table 52. Bayer AG Renal Therapeutic Product Offerings
Table 53. Bayer AG Renal Therapeutic Revenue (US$, Mn), (2017-2022)
Table 54. AstraZeneca Corporate Summary
Table 55. AstraZeneca Renal Therapeutic Product Offerings
Table 56. AstraZeneca Renal Therapeutic Revenue (US$, Mn), (2017-2022)
Table 57. Vifor Pharma Group Corporate Summary
Table 58. Vifor Pharma Group Renal Therapeutic Product Offerings
Table 59. Vifor Pharma Group Renal Therapeutic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Renal Therapeutic Segment by Drug Type in 2021
Figure 2. Renal Therapeutic Segment by Application in 2021
Figure 3. Global Renal Therapeutic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Renal Therapeutic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Renal Therapeutic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Renal Therapeutic Revenue in 2021
Figure 8. By Drug Type - Global Renal Therapeutic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Renal Therapeutic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Renal Therapeutic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Renal Therapeutic Revenue Market Share, 2017-2028
Figure 12. US Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Renal Therapeutic Revenue Market Share, 2017-2028
Figure 16. Germany Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 17. France Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Renal Therapeutic Revenue Market Share, 2017-2028
Figure 24. China Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 28. India Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Renal Therapeutic Revenue Market Share, 2017-2028
Figure 30. Brazil Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Renal Therapeutic Revenue Market Share, 2017-2028
Figure 33. Turkey Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Renal Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 37. Merck & Co., Inc. Renal Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Company Renal Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis AG Renal Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Inc. Renal Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Vifor Pharma Inc. Renal Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Johnson & Johnson Services, Inc. Renal Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Amgen Inc. Renal Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bayer AG Renal Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. AstraZeneca Renal Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Vifor Pharma Group Renal Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)